146 related articles for article (PubMed ID: 30985428)
1. Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT.
Hod N; Lantsberg S; Anconina R; Levin D; Nalbandyan K; Levi I
Clin Nucl Med; 2019 Jun; 44(6):e409-e412. PubMed ID: 30985428
[TBL] [Abstract][Full Text] [Related]
2. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
[TBL] [Abstract][Full Text] [Related]
3. Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic Findings.
Fang H; Chuang HH; Strati P; Hu S; Shuai W; Medeiros LJ; Wang W
Am J Surg Pathol; 2021 Feb; 45(2):160-168. PubMed ID: 32769427
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory Pseudotumor of Intestine Mimicking Lymphoma on 18F-FDG PET/CT.
Xue Q; Miao W
Clin Nucl Med; 2020 May; 45(5):383-384. PubMed ID: 32149811
[TBL] [Abstract][Full Text] [Related]
5. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on
Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S
Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?
Spaepen K; Stroobants S; Dupont P; Van Steenweghen S; Thomas J; Vandenberghe P; Vanuytsel L; Bormans G; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
J Clin Oncol; 2001 Jan; 19(2):414-9. PubMed ID: 11208833
[TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT Findings in Multiple Splenic Amebomas (Amebic Granulomas).
Dong A; Wang Y; Zuo C; Zhu H
Clin Nucl Med; 2016 May; 41(5):379-81. PubMed ID: 26505858
[TBL] [Abstract][Full Text] [Related]
8. Postchemotherapy histiocyte-rich pseudotumor involving the spleen.
Chandra P; Wen YH; Tuli S; Raphael BG; Amorosi EL; Medeiros LJ; Ibrahim S
Am J Clin Pathol; 2009 Sep; 132(3):342-8. PubMed ID: 19687310
[TBL] [Abstract][Full Text] [Related]
9. F-18 fluorodeoxyglucose accumulation in an inflammatory pseudotumor of the spleen.
Sato M; Takasaka I; Okumura T; Shioyama Y; Asato Y; Yoshimi F; Imura J; Amemiya R
Ann Nucl Med; 2007 Nov; 21(9):521-4. PubMed ID: 18030584
[TBL] [Abstract][Full Text] [Related]
10. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphoma.
Kostakoglu L; Leonard JP; Kuji I; Coleman M; Vallabhajosula S; Goldsmith SJ
Cancer; 2002 Feb; 94(4):879-88. PubMed ID: 11920454
[TBL] [Abstract][Full Text] [Related]
11. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas.
Specht L
Semin Radiat Oncol; 2007 Jul; 17(3):190-7. PubMed ID: 17591566
[TBL] [Abstract][Full Text] [Related]
12. Targeting personalized medicine in a non-Hodgkin lymphoma patient with 18F-FDG and 18F-choline PET/CT.
Ribeiro TH; S R; Castro AC; Paulino E; Mamede M
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):109-111. PubMed ID: 28355370
[TBL] [Abstract][Full Text] [Related]
13. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD.
Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M
Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392
[TBL] [Abstract][Full Text] [Related]
14. Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission.
Morbelli S; Capitanio S; De Carli F; Bongioanni F; De Astis E; Miglino M; Verardi MT; Buschiazzo A; Fiz F; Marini C; Pomposelli E; Sambuceti G
Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):232-239. PubMed ID: 26283504
[TBL] [Abstract][Full Text] [Related]
15. A Case of Low-Grade Primary Cardiac Lymphoma with Pericardial Effusion Diagnosed by Combined 18F-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) Imaging and Effusion Cytology.
Fukunaga H; Tatewaki Y; Mutoh T; Shimomura H; Yamamoto S; Terao C; Totsune T; Nakagawa M; Taki Y
Am J Case Rep; 2018 Mar; 19():292-295. PubMed ID: 29535291
[TBL] [Abstract][Full Text] [Related]
16. Splenic histiocyte-rich pseudotumor following chemotherapy for non Hodgkin diffuse large B cell lymphoma.
Abdou AG; Kandil M; Eldien MS; Abdallah R
Pathologica; 2016 Sep; 108(3):140-143. PubMed ID: 28195266
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 18FDG-PET with CT scans in the evaluation of patients with residual and recurrent Hodgkin's lymphoma.
Dittmann H; Sokler M; Kollmannsberger C; Dohmen BM; Baumann C; Kopp A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Oncol Rep; 2001; 8(6):1393-9. PubMed ID: 11605073
[TBL] [Abstract][Full Text] [Related]
18. Potential pitfall of FDG PET/CT in assessing residual masses postchemotherapy.
Lu SJ; Wong AS; Seet JE; Hao C; Sinha A
Clin Nucl Med; 2013 Apr; 38(4):e200-4. PubMed ID: 23455529
[TBL] [Abstract][Full Text] [Related]
19. Cat-Scratch Disease: A Pitfall for Lymphoma Evaluation by FDG-PET/CT.
Dubreuil J; Dony A; Salles G; Traverse-Glehen A; Giammarile F; Skanjeti A
Clin Nucl Med; 2017 Feb; 42(2):106-107. PubMed ID: 27997427
[TBL] [Abstract][Full Text] [Related]
20. Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.
de Wit M; Bumann D; Beyer W; Herbst K; Clausen M; Hossfeld DK
Ann Oncol; 1997; 8 Suppl 1():57-60. PubMed ID: 9187431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
